Great ethical divides: Bridging the gap between institutional review boards
If an institution has an Institutional Review Board
, librarians are a logical choice to be included as a member of the IRB, as long as they themselves are interested in research and have a proven record of research and publication.
Ethical Imperialism: Institutional Review Boards
and the Social Sciences 1965-2009 (reprint, 2010)
Amdur (radiation oncology, University of Florida College of Medicine) and Bankert (Committee for the Protection of Human Subjects, Dartmouth College) give Institutional Review Board
(IRB) members and administrators information they need to protect human research subjects in compliance with federal regulations.
Following 10 months of debate on medical, ethical and psychological issues, the Cleveland Clinic announced on October 15th that it is the first institution in the world to receive institutional review board
approval to perform a human face transplant on someone who is severely disfigured by burns or disease.
These data were collected as part of an outbreak investigation and therefore were exempt from formal institutional review board
Ethical research requires that couples give informed consent to donate spare embryos, that embryos not be bought or sold, that they are not allowed to cleave more than 14 days post fertilization, and that researchers obtain institutional review board
approval and expect to obtain important clinical data from their work.
"Any physician who participated in human cloning at this time would be doing human experimentation without the necessary first steps of successful trials in animals and approval from the appropriate institutional review board
. This would be both unethical and unprofessional," Dr.
For example, in an October 1993 press statement, Stillman said the experiment was approved by the Institutional Review Board
(IRB) and the Ethics Committee of the Medical Center." The IRB is a group of professionals that reviews all requests to conduct research related to human subjects at GW.
M2 PHARMA-December 14, 2018-Check-Cap to launch US Pilot Study of C-Scan upon review and approval by Institutional Review Board
Trovagene have received Institutional Review Board
approval from Dana-Farber/Harvard Cancer Center and its Phase 2 clinical trial of PCM-075 in combination with Zytiga and prednisone in metastatic Castration-Resistant Prostate Cancer is officially activated and recruiting patients.
Special Notice:National Institutes of Health has issued new policy on the Use of a Single Institutional Review Board
for Multi-Site Research.